Initial Management and Follow-up of Differentiated Thyroid Cancer in Children

Restricted access

Children with differentiated thyroid cancer (DTC) often present with metastatic disease and have a high risk for recurrence, but rarely die of the disease. This article reviews DTC in children and discusses current approaches to their initial care and follow-up. These recommendations take into account the greater risk for recurrence and lower disease-specific mortality in these patients. Total thyroidectomy and central compartment lymph node dissection are appropriate for most children, but should be performed by a high-volume thyroid surgeon. Radioactive iodine (RAI) should generally be prescribed for those at very high risk for recurrence or known to have microscopic residual disease, and those with iodine-avid distant metastases. RAI should be considered in other patients only after carefully weighing the relative risks and benefits and the aggressiveness of the clinical presentation, because RAI may be associated with an increased risk for second malignancies and an increase in overall morbidity and mortality. All patients should be treated with thyroid hormone suppression, and follow-up should be lifelong. However, the degree of thyroid hormone suppression and frequency of disease surveillance usually decrease over time as patients are determined to be disease-free.

Correspondence: Gary Francis, MD, PhD, Division of Pediatric Endocrinology and Metabolism, Virginia Commonwealth University, 1001 East Marshall Street, Richmond, VA 23298. E-mail: glfrancis@vcu.edu
  • 1.

    American Cancer Society. Cancer Facts & Figures 2009. Atlanta, GA: American Cancer Society; 2009.

  • 2.

    Horner MJ, Ries LAG, Krapcho M, eds. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009. Accessed October 6, 2010.

    • Search Google Scholar
    • Export Citation
  • 3.

    Hogan AR, Zhuge Y, Perez EA. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res 2009;156:167172.

  • 4.

    Waguespack S, Wells S, Ross J, Bleyer A. Thyroid cancer. In: Bleyer A, O'Leary M, Barr R, Ries L, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival 1975-2000. Vol. NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute; 2006:143154.

    • Search Google Scholar
    • Export Citation
  • 5.

    Demidchik YE, Saenko VA, Yamashita S. Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present. Arq Bras Endocrinol Metabol 2007;51:748762.

    • Search Google Scholar
    • Export Citation
  • 6.

    Wu XC, Chen VW, Steele B. Cancer incidence in adolescents and young adults in the United States, 1992–1997. J Adolesc Health 2003;32:405415.

    • Search Google Scholar
    • Export Citation
  • 7.

    Spoudeas HA, ed. Paediatric endocrine tumours. A multi-disciplinary consensus statement of best practice from a working group convened under the auspices of the the British Society of Paediatric Endocrinology & Diabetes and the United Kingdom Children's Cancer Study Group. West Sussex, United Kingdom: Novo Nordisk Ltd; 2005.

    • Search Google Scholar
    • Export Citation
  • 8.

    Halac I, Zimmerman D. Thyroid nodules and cancers in children. Endocrinol Metab Clin North Am 2005;34:725744.

  • 9.

    Harness JK, Thompson NW, McLeod MK. Differentiated thyroid carcinoma in children and adolescents. World J Surg 1992;16:547553.

  • 10.

    Demidchik YE, Demidchik EP, Reiners C. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 2006;243:525532.

    • Search Google Scholar
    • Export Citation
  • 11.

    DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and Genetics of Tumours of Endocrine Organs. World Health Organization Classification of Tumours, Volume 8. Lyon, France: IARC Press; 2004.

    • Search Google Scholar
    • Export Citation
  • 12.

    Harach HR, Williams ED. Childhood thyroid cancer in England and Wales. Br J Cancer 1995;72:777783.

  • 13.

    Zimmerman D, Hay ID, Gough IR. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 1988;104:11571166.

    • Search Google Scholar
    • Export Citation
  • 14.

    Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid 2002;12:683702.

    • Search Google Scholar
    • Export Citation
  • 15.

    Borson-Chazot F, Causeret S, Lifante JC. Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer. World J Surg 2004;28:10881092.

    • Search Google Scholar
    • Export Citation
  • 16.

    Schneider AB. Radiation-induced thyroid cancer. Available at: http://www.uptodate.com/patients/content/topic.do?topicKey=~dyVVqDEHRC2tDW. Accessed October 6, 2010.

    • Search Google Scholar
    • Export Citation
  • 17.

    Tucker MA, Jones PH, Boice JD Jr. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res 1991;51:28852888.

    • Search Google Scholar
    • Export Citation
  • 18.

    Schlumberger M, Pacini F. Thyroid Tumors. Paris, France: Nucleon; 2003.

  • 19.

    Faggiano A, Coulot J, Bellon N. Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue. J Nucl Med 2004;45:232237.

    • Search Google Scholar
    • Export Citation
  • 20.

    Naing S, Collins BJ, Schneider AB. Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence. Thyroid 2009;19:479485.

    • Search Google Scholar
    • Export Citation
  • 21.

    Sobrinho-Simoes M, Maximo V, Rocha AS. Intragenic mutations in thyroid cancer. Endocrinol Metab Clin North Am 2008;37:333362.

  • 22.

    Woyach J, Shah M. New therapeutic advances in the management of progressive thyroid cancer. Endocr Relat Cancer 2009;16:715731.

  • 23.

    Yamashita S, Saenko V. Mechanisms of disease: molecular genetics of childhood thyroid cancers. Nat Clin Pract Endocrinol Metab 2007;3:422429.

    • Search Google Scholar
    • Export Citation
  • 24.

    Kebebew E. Hereditary non-medullary thyroid cancer. World J Surg 2008;32:678682.

  • 25.

    Alsanea O, Wada N, Ain K. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 2000;128:10431051.

    • Search Google Scholar
    • Export Citation
  • 26.

    Welch Dinauer CA, Tuttle RM, Robie DK. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 1998;49:619628.

    • Search Google Scholar
    • Export Citation
  • 27.

    Feinmesser R, Lubin E, Segal K, Noyek A. Carcinoma of the thyroid in children—a review. J Pediatr Endocrinol Metab 1997;10:561568.

  • 28.

    Frankenthaler RA, Sellin RV, Cangir A, Goepfert H. Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg 1990;160:341343.

    • Search Google Scholar
    • Export Citation
  • 29.

    Vassilopoulou-Sellin R, Klein MJ, Smith TH. Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer 1993;71:13481352.

    • Search Google Scholar
    • Export Citation
  • 30.

    Cooper DS, Doherty GM, Haugen BR. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:11671214.

    • Search Google Scholar
    • Export Citation
  • 31.

    Tuttle RM, Ball DW, Byrd D. NCCN clinical practice guidelines in oncology: thyroid carcinoma, version 1, 2010. Available at: http://www.nccn.org/professionals/physician_gls/PDF/thyroid.pdf. Accessed October 6, 2010.

    • Search Google Scholar
    • Export Citation
  • 32.

    AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 2001;7:202220.

    • Search Google Scholar
    • Export Citation
  • 33.

    Guidelines for the Management of Thyroid Cancer, 2nd ed. London, United Kingdom: Royal College of Physicians; 2007.

  • 34.

    Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer 2006;13:427453.

  • 35.

    Gharib H, Papini E, Valcavi R. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006;12:63102.

    • Search Google Scholar
    • Export Citation
  • 36.

    Wada N, Sugino K, Mimura T. Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival. BMC Cancer 2009;9:306.

    • Search Google Scholar
    • Export Citation
  • 37.

    Schlumberger M, De Vathaire F, Travagli JP. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 1987;65:10881094.

    • Search Google Scholar
    • Export Citation
  • 38.

    Bal CS, Kumar A, Chandra P. Is chest x-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer? Thyroid 2004;14:217225.

    • Search Google Scholar
    • Export Citation
  • 39.

    O'Gorman CS, Hamilton J, Rachmiel M. Thyroid cancer in childhood: a retrospective review of childhood course. Thyroid 2010;20:375380.

  • 40.

    Hay ID, Gonzalez-Losada T, Reinalda MS. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 2010;34:11921202.

    • Search Google Scholar
    • Export Citation
  • 41.

    Vassilopoulou-Sellin R, Goepfert H, Raney B, Schultz PN. Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up. Head Neck 1998;20:549555.

    • Search Google Scholar
    • Export Citation
  • 42.

    Xing M, Westra WH, Tufano RP. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005;90:63736379.

    • Search Google Scholar
    • Export Citation
  • 43.

    Penko K, Livezey J, Fenton C. BRAF mutations are uncommon in papillary thyroid cancer of young patients. Thyroid 2005;15:320325.

  • 44.

    Kouvaraki MA, Shapiro SE, Fornage BD. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003;134:946954.

    • Search Google Scholar
    • Export Citation
  • 45.

    Lang BH, Chow SM, Lo CY. Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers. Ann Surg 2007;246:114121.

  • 46.

    Grubbs EG, Rich TA, Li G. Recent advances in thyroid cancer. Curr Probl Surg 2008;45:156250.

  • 47.

    Powers PA, Dinauer CA, Tuttle RM, Francis GL. The MACIS score predicts the clinical course of papillary thyroid carcinoma in children and adolescents. J Pediatr Endocrinol Metab 2004;17:339343.

    • Search Google Scholar
    • Export Citation
  • 48.

    Shaha AR. TNM classification of thyroid carcinoma. World J Surg 2007;31:879887.

  • 49.

    Wada N, Sugino K, Mimura T. Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation. Ann Surg Oncol 2009;16:34423449.

    • Search Google Scholar
    • Export Citation
  • 50.

    La Quaglia MP, Black T, Holcomb GW III. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg 2000;35:955959; discussion 960.

    • Search Google Scholar
    • Export Citation
  • 51.

    Landau D, Vini L, A'Hern R, Harmer C. Thyroid cancer in children: the Royal Marsden Hospital experience. Eur J Cancer 2000;36:214220.

  • 52.

    Brink JS, van Heerden JA, McIver B. Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 2000;128:881886; discussion 886–887.

    • Search Google Scholar
    • Export Citation
  • 53.

    Durante C, Haddy N, Baudin E. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91:28922899.

    • Search Google Scholar
    • Export Citation
  • 54.

    Patel A, Jhiang S, Dogra S. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents. Pediatr Res 2002;52:737744.

    • Search Google Scholar
    • Export Citation
  • 55.

    Lee YM, Lo CY, Lam KY. Well-differentiated thyroid carcinoma in Hong Kong Chinese patients under 21 years of age: a 35-year experience. J Am Coll Surg 2002;194:711716.

    • Search Google Scholar
    • Export Citation
  • 56.

    Harach HR, Williams ED. Childhood thyroid cancer in England and Wales. Br J Cancer 1995;72:777783.

  • 57.

    Bal CS, Padhy AK, Kumar A. Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone. Nucl Med Commun 2001;22:881-887.

    • Search Google Scholar
    • Export Citation
  • 58.

    Lazar L, Lebenthal Y, Steinmetz A. Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. J Pediatr 2009;154:708714.

    • Search Google Scholar
    • Export Citation
  • 59.

    Sosa JA, Tuggle CT, Wang TS. Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab 2008;93:30583065.

    • Search Google Scholar
    • Export Citation
  • 60.

    Thompson GB, Hay ID. Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma. World J Surg 2004;28:11871198.

    • Search Google Scholar
    • Export Citation
  • 61.

    Tuggle CT, Roman SA, Wang TS. Pediatric endocrine surgery: who is operating on our children? Surgery 2008;144:869877; discussion 877.

  • 62.

    Welch Dinauer CA, Tuttle RM, Robie DK. Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma. J Pediatr Surg 1999;34:17991804.

    • Search Google Scholar
    • Export Citation
  • 63.

    Jarzab B, Handkiewicz Junak D, Wloch J. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med 2000;27:833841.

    • Search Google Scholar
    • Export Citation
  • 64.

    Bilimoria KY, Bentrem DJ, Ko CY. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375381.

  • 65.

    Rachmiel M, Charron M, Gupta A. Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma. J Pediatr Endocrinol Metab 2006;19:13771393.

    • Search Google Scholar
    • Export Citation
  • 66.

    Hay ID, Bergstralh EJ, Goellner JR. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:10501057; discussion 1057–1058.

    • Search Google Scholar
    • Export Citation
  • 67.

    Shah MD, Hall FT, Eski SJ. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 2003;113:21022107.

  • 68.

    Pacini F, Capezzone M, Elisei R. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 2002;87:14991501.

    • Search Google Scholar
    • Export Citation
  • 69.

    Demidchik IuE, Kontratovich VA. [Repeat surgery for recurrent thyroid cancer in children]. Vopr Onkol 2003;49:366369 [in Russian].

  • 70.

    Newman KD, Black T, Heller G. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg 1998;227:533541.

    • Search Google Scholar
    • Export Citation
  • 71.

    Musacchio MJ, Kim AW, Vijungco JD, Prinz RA. Greater local recurrence occurs with ``berry picking'' than neck dissection in thyroid cancer. Am Surg 2003;69:191196; discussion 196–197.

    • Search Google Scholar
    • Export Citation
  • 72.

    van Santen HM, Aronson DC, Vulsma T. Frequent adverse events after treatment for childhood-onset differentiated thyroid carcinoma: a single institute experience. Eur J Cancer 2004;40:17431751.

    • Search Google Scholar
    • Export Citation
  • 73.

    Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418428.

    • Search Google Scholar
    • Export Citation
  • 74.

    Jonklaas J, Sarlis NJ, Litofsky D. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 2006;16:12291242.

    • Search Google Scholar
    • Export Citation
  • 75.

    Sawka AM, Brierley JD, Tsang RW. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 2008;37:457480.

    • Search Google Scholar
    • Export Citation
  • 76.

    Chow S, Law S, Mendenhall W. Differentiated thyroid carcinoma in childhood and adolescence—clinical course and role of radioiodine. Pediatr Blood Cancer 2004;42:176183.

    • Search Google Scholar
    • Export Citation
  • 77.

    Sawka AM, Lakra DC, Lea J. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf) 2008;69:479490.

    • Search Google Scholar
    • Export Citation
  • 78.

    Sawka AM, Lea J, Alshehri B. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol (Oxf) 2008;68:610617.

    • Search Google Scholar
    • Export Citation
  • 79.

    Meier DA, Brill DR, Becker DV. Procedure guideline for therapy of thyroid disease with (131)iodine. J Nucl Med 2002;43:856861.

  • 80.

    Brown AP, Chen J, Hitchcock YJ. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 2008;93:504515.

    • Search Google Scholar
    • Export Citation
  • 81.

    Dottorini ME, Vignati A, Mazzucchelli L. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med 1997;38:669675.

    • Search Google Scholar
    • Export Citation
  • 82.

    Sawka AM, Thabane L, Parlea L. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 2009;19:451457.

    • Search Google Scholar
    • Export Citation
  • 83.

    Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid 2003;13:265271.

  • 84.

    Bhattacharyya N, Chien W. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma. Ann Otol Rhinol Laryngol 2006;115:607610.

    • Search Google Scholar
    • Export Citation
  • 85.

    Dinauer C, Francis GL. Thyroid cancer in children. Endocrinol Metab Clin North Am 2007;36:779806.

  • 86.

    Kuijt WJ, Huang SA. Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal. J Clin Endocrinol Metab 2005;90:61236125.

    • Search Google Scholar
    • Export Citation
  • 87.

    Pacini F, Schlumberger M, Dralle H. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787803.

    • Search Google Scholar
    • Export Citation
  • 88.

    Tuttle RM, Brokhin M, Omry G. Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal. J Nucl Med 2008;49:764770.

    • Search Google Scholar
    • Export Citation
  • 89.

    Hanscheid H, Lassmann M, Luster M. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med 2006;47:648654.

    • Search Google Scholar
    • Export Citation
  • 90.

    Lau WF, Zacharin MR, Waters K. Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy. Intern Med J 2006;36:564570.

    • Search Google Scholar
    • Export Citation
  • 91.

    Luster M, Handkiewicz-Junak D, Grossi A. Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study. J Clin Endocrinol Metab 2009;94:39483953.

    • Search Google Scholar
    • Export Citation
  • 92.

    Leboulleux S, Baudin E, Hartl DW. Follicular cell-derived thyroid cancer in children. Horm Res 2005;63:145151.

  • 93.

    Reynolds JC. Comparison of I-131 absorbed radiation doses in children and adults: a tool for estimating therapeutic I-131 doses in children. In: Robbins JM, ed. Treatment of Thyroid Cancer in Childhood. Bethesda, MD: NIDDK, National Institutes of Health; 1992:127135.

    • Search Google Scholar
    • Export Citation
  • 94.

    Tuttle RM, Leboeuf R, Robbins RJ. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer. J Nucl Med 2006;47:15871591.

    • Search Google Scholar
    • Export Citation
  • 95.

    Lassmann M, Reiners C, Luster M. Dosimetry and thyroid cancer—the individual dosage of radioiodine. Endocr Relat Cancer 2010;17:R161172.

  • 96.

    Dorn R, Kopp J, Vogt H. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach. J Nucl Med 2003;44:451456.

    • Search Google Scholar
    • Export Citation
  • 97.

    Maxon HR. The role of radioiodine in the treatment of childhood thyroid cancer—a dosimetric approach. In: Robbins JM, ed. Treatment of Thyroid Cancer in Childhood. Bethesda, MD: NIDDK, National Institutes of Health; 1992:109126.

    • Search Google Scholar
    • Export Citation
  • 98.

    Maxon HR, Thomas SR, Hertzberg VS. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983;309:937941.

    • Search Google Scholar
    • Export Citation
  • 99.

    Reynolds JC, Robbins J. The changing role of radioiodine in the management of differentiated thyroid cancer. Semin Nucl Med 1997;27:152164.

    • Search Google Scholar
    • Export Citation
  • 100.

    Tuttle RM, Grewal RK, Larson SM. Radioactive iodine therapy in poorly differentiated thyroid cancer. Nat Clin Pract Oncol 2007;4:665668.

  • 101.

    Taylor T, Specker B, Robbins J. Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 1998;129:622627.

    • Search Google Scholar
    • Export Citation
  • 102.

    Asari R, Koperek O, Scheuba C. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg 2009;249:10231031.

    • Search Google Scholar
    • Export Citation
  • 103.

    Zou CC, Zhao ZY, Liang L. Childhood minimally invasive follicular carcinoma: clinical features and immunohistochemistry analysis. J Paediatr Child Health 2010;46:166170.

    • Search Google Scholar
    • Export Citation
  • 104.

    Biondi B, Filetti S, Schlumberger M. Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 2005;1:3240.

    • Search Google Scholar
    • Export Citation
  • 105.

    Schlumberger M, De Vathaire F, Travagli JP. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 1987;65:10881094.

    • Search Google Scholar
    • Export Citation
  • 106.

    Mazzaferri EL, Robbins RJ, Spencer CA. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003;88:14331441.

    • Search Google Scholar
    • Export Citation
  • 107.

    Baudin E, Do Cao C, Cailleux AF. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 2003;88:11071111.

    • Search Google Scholar
    • Export Citation
  • 108.

    Bauer AJ, RM Tuttle, Francis G. Thyroid nodules and thyroid carcinoma in children. In: Pescovitz O, Eugster E, eds. Pediatric Endocrinology: Mechanisms, Manifestations, and Management. Philadelphia, PA: Lippincott, Inc; 2004.

    • Search Google Scholar
    • Export Citation
  • 109.

    LaQuaglia M, Black T, Holcomb G. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg 2000;35:955959.

    • Search Google Scholar
    • Export Citation
  • 110.

    Iorcansky S, Herzovich V, Qualey RR, Tuttle RM. Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer. J Clin Endocrinol Metab 2005;90:65536555.

    • Search Google Scholar
    • Export Citation
  • 111.

    Hoe FM, Charron M, Moshang T Jr. Use of the recombinant human TSH stimulated thyroglobulin level and diagnostic whole body scan in children with differentiated thyroid carcinoma. J Pediatr Endocrinol Metab 2006;19:2530.

    • Search Google Scholar
    • Export Citation
  • 112.

    Antonelli A, Miccoli P, Fallahi P. Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. Thyroid 2003;13:479484.

    • Search Google Scholar
    • Export Citation
  • 113.

    Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998;39:15311536.

    • Search Google Scholar
    • Export Citation
  • 114.

    Spencer CA, Takeuchi M, Kazarosyan M. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998;83:11211127.

    • Search Google Scholar
    • Export Citation
  • 115.

    Chiovato L, Latrofa F, Braverman LE. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003;139:346351.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 497 225 3
PDF Downloads 52 41 1
EPUB Downloads 0 0 0